Pre-Applications to Sprout Program Due 4/17

Sprout logoThe Sprout Program is back!

Funded by the Provost’s Office and the Office of Technology Licensing (OTL), Sprout is designed to encourage and support translational research activity within the Brandeis community for faculty, postdocs, and student researchers (graduate and undergraduate) in the Division of Science. The awards (up to $25,000 – no overhead!) are intended to help to advance early-stage technologies to industry adoption thereby bringing your research and entrepreneurial ambitions to life.

Successful pre-applicants will be invited to submit a final application due in late May and to pitch to a panel of industry judges in early June. Pre-apply by April 17.

Division of Science Confers Degrees at 2022 Brandeis Commencement

Jane Kondev and students 2022 commencement

Jané Kondev, Professor of Physics, and students at the 2022 Brandeis commencement

Brandeis University held its 71st commencement on May 22nd. The 16 departments and programs that make up the Division of Science granted degrees at the bachelor’s, master’s and PhD levels.  There were 556 degrees granted to the undergraduates of the Division of Science. This was 41% of the total number of Brandeis undergraduate degrees conferred at the commencement.

Additionally, 47 PhD degrees from the Biochemistry and Biophysics, Chemistry, Computer Science, Mathematics, Molecular and Cell Biology, Neuroscience, Physics and Psychology program were awarded. These graduate programs as well as Computational Linguistics, Biotechnology, and Genetic Counseling granted 95 Master’s degrees.

Congratulations to all!

 

 

 

 

 

 

 

SciFest XI to be held on Thursday, 8/11/22

Save the Date for SciFest!

SciFest, the Division of Science’s annual celebration of undergraduate research, is a poster session featuring work done by undergraduates in Brandeis laboratories each summer. This is a capstone event for the undergraduate researchers where they can present the results of their research to peers, grad students, and faculty.

Join us for the SciFest XI which will be held on Thursday, August 11, 2022 in the Shapiro Science Center.

Ordabayev et al. developed an open-source analysis software for colocalization single-molecule fluorescence experiments

Tapqir analysis

Yerdos Ordabayev et al. in the Department of Biochemistry use Bayesian probabilistic programming to implement computer software “Tapqir” for analysis of colocalization single-molecule spectroscopy (CoSMoS) image data. CoSMoS is a tool widely used in vitro to study the biochemical and physical mechanisms of the protein and nucleic acid macromolecular “machines” that perform essential biological functions. In this method, formation and/or dissociation of molecular complexes is observed by single-molecule fluorescence microscopy as the colocalization of binder and target macromolecules each labeled with a different color of fluorescent dye. Despite the use of the method for over twenty years, reliable analysis of CoSMoS data remains a significant challenge to the effective and more widespread use of the technique.

This work describes a holistic causal probabilistic model of CoSMoS image data formation. This model is physics-based and includes realistic shot noise in fluorescent spots, camera noise, the size and shape of spots, and the presence of both specific and nonspecific binder molecules in the images. Most importantly, instead of yielding a binary spot-/no-spot determination, the algorithm calculates the probability of a colocalization event. Unlike alternative approaches, Tapqir does not require subjective threshold settings of parameters so they can be used effectively and accurately by non-expert analysts. The program is implemented in the state-of-the-art Python-based probabilistic programming language Pyro (open-sourced by Uber AI Labs in 2017), which enables efficient use of graphics processing unit (GPU)-based hardware for rapid parallel processing of data and facilitates future modifications to the model. Tapqir is free, open-source software. We envision that Tapqir program is likely to be adopted by researchers who use single-molecule colocalization methods to study a wide range of different biological systems.

Reference:
Yerdos A Ordabayev, Larry J Friedman, Jeff Gelles, Douglas L Theobald. Bayesian machine learning analysis of single-molecule fluorescence colocalization images. eLife 2022;11:e73860.
Publication Date: March 23, 2022.

Drew Weissman ’81, MA ’81 Receives the Lasker Award

Drew WeissmanKatalin Karikó and Drew Weissman ’81, MA ’81 have received the Lasker-DeBakey Clinical Medical Research Award. Weissman is a professor of medicine at the Perelman School of Medicine at the University of Pennsylvania. Karikó is a senior vice president at BioNTech RNA Pharmaceuticals. The Lasker award is in recognition of their research into messenger RNA and the resulting therapeutic technology. It was their work that was so crucial in the rapid development of the COVID-19 vaccines. It should be noted that many winners of the Lasker award go on to receive the Nobel Prize.

Weissman and Kariko also received the Lewis S. Rosenstiel Award for Distinguished Work in Basic Medical Research award earlier this year.

The Washington Post profiled Weissman and his work in a recent article, “A scientific hunch. Then silence. Until the world needed a lifesaving vaccine.”

View Lasker acceptance remarks from Katalin Karikó and Drew Weissman.

 

 

Brandeis Alumnus Receives Breakthrough Prize

Drew WeissmanBrandeis alumnus, Drew Weissman, ’81, MA ’81, P’15 along with Katalin Karikó have been awarded the Breakthrough Prize in Life Sciences.  Weissman and Karikó received the Lewis S. Rosenstiel Award for Distinguished Work in Basic Medical Research from Brandeis earlier this year.

While the Breakthrough Prize is considered the world’s largest science prize at $3 million, it is one of the many awards that Weissman and Kariko have been receiving as a result of their decades of research into mRNA therapies. It is this research that has led to the innovative COVID-19 vaccines developed by Pfizer/BioNTech and Moderna.

After earning his BA and MA degrees from Brandeis, Weissman went on to receive his PhD in Immunology from Boston University in 1987. He did a postdoctoral fellowship at the National Institutes of Health under Anthony Fauci. He is now a professor at University of Pennsylvania’s Perelman School of Medicine.

Additional information:

Protected by Akismet
Blog with WordPress

Welcome Guest | Login (Brandeis Members Only)